Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14


Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism.

Kočovská E, Gaughran F, Krivoy A, Meier UC.

Front Psychiatry. 2017 Mar 27;8:47. doi: 10.3389/fpsyt.2017.00047. eCollection 2017. Review.


Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.

Rhead B, Bäärnhielm M, Gianfrancesco M, Mok A, Shao X, Quach H, Shen L, Schaefer C, Link J, Gyllenberg A, Hedström AK, Olsson T, Hillert J, Kockum I, Glymour MM, Alfredsson L, Barcellos LF.

Neurol Genet. 2016 Sep 13;2(5):e97. doi: 10.1212/NXG.0000000000000097. eCollection 2016 Oct.


Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?

Arboleda JF, Urcuqui-Inchima S.

Adv Virol. 2016;2016:1016840. doi: 10.1155/2016/1016840. Epub 2016 May 11. Review.


Latitudinal Clines of the Human Vitamin D Receptor and Skin Color Genes.

Tiosano D, Audi L, Climer S, Zhang W, Templeton AR, Fernández-Cancio M, Gershoni-Baruch R, Sánchez-Muro JM, El Kholy M, Hochberg Z.

G3 (Bethesda). 2016 May 3;6(5):1251-66. doi: 10.1534/g3.115.026773.


EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy.

Ricigliano VA, Handel AE, Sandve GK, Annibali V, Ristori G, Mechelli R, Cader MZ, Salvetti M.

PLoS One. 2015 Apr 8;10(4):e0119605. doi: 10.1371/journal.pone.0119605. eCollection 2015.


Noise in multiple sclerosis: unwanted and necessary.

Bordi I, Ricigliano VA, Umeton R, Ristori G, Grassi F, Crisanti A, Sutera A, Salvetti M.

Ann Clin Transl Neurol. 2014 Jul;1(7):502-11. doi: 10.1002/acn3.72. Epub 2014 Jun 19.


Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis.

Khsheibun R, Paperna T, Volkowich A, Lejbkowicz I, Avidan N, Miller A.

PLoS One. 2014 Jul 15;9(7):e102331. doi: 10.1371/journal.pone.0102331. eCollection 2014.


The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer.

Sharma NL, Massie CE, Butter F, Mann M, Bon H, Ramos-Montoya A, Menon S, Stark R, Lamb AD, Scott HE, Warren AY, Neal DE, Mills IG.

Nucleic Acids Res. 2014 Jun;42(10):6256-69. doi: 10.1093/nar/gku281. Epub 2014 Apr 21.


Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.

Sisay S, Pryce G, Jackson SJ, Tanner C, Ross RA, Michael GJ, Selwood DL, Giovannoni G, Baker D.

PLoS One. 2013 Oct 9;8(10):e76907. doi: 10.1371/journal.pone.0076907. eCollection 2013.


What is the Real Fate of Vitamin D in Multiple Sclerosis?

Shaygannejad V, Tolou-Ghamari Z.

Int J Prev Med. 2013 May;4(Suppl 2):S159-64.


A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.

Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano VA, Vittori D, Fornasiero A, Buscarinu MC; International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium,2, Romano S, Salvetti M, Ristori G.

PLoS One. 2013 May 16;8(5):e63300. doi: 10.1371/journal.pone.0063300. Print 2013.


Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Pierrot-Deseilligny C, Souberbielle JC.

Ther Adv Neurol Disord. 2013 Mar;6(2):81-116. doi: 10.1177/1756285612473513.


The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.

Giangreco AA, Nonn L.

J Steroid Biochem Mol Biol. 2013 Jul;136:86-93. doi: 10.1016/j.jsbmb.2013.01.001. Epub 2013 Jan 16. Review.


Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.

O'Gorman C, Lucas R, Taylor B.

Int J Mol Sci. 2012;13(9):11718-52. doi: 10.3390/ijms130911718. Epub 2012 Sep 18. Review.

Supplemental Content

Support Center